Agios Pharmaceuticals
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 386
- Market Cap
- $2.6B
- Website
- http://www.agios.com
- Introduction
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation
Phase 1
Completed
- Conditions
- Acute Myeloid Leukemia (AML)Hematologic MalignanciesMyelodysplastic Syndrome
- Interventions
- First Posted Date
- 2015-07-09
- Last Posted Date
- 2019-03-08
- Lead Sponsor
- Agios Pharmaceuticals, Inc.
- Target Recruit Count
- 46
- Registration Number
- NCT02492737
Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-AG-120
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: [14C]-AG-120
- First Posted Date
- 2015-07-03
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Agios Pharmaceuticals, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT02489513
- Locations
- 🇺🇸
Research Site, Madison, Wisconsin, United States
A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency
- First Posted Date
- 2015-06-22
- Last Posted Date
- 2025-05-02
- Lead Sponsor
- Agios Pharmaceuticals, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT02476916
- Locations
- 🇫🇷
Hôpital Saint-Vincent de Paul, Lille, Nord, France
🇳🇱Universitair Medisch Centrum Utrecht, Utrecht, Netherlands
🇺🇸Wayne State University School of Medicine - Children's Hospital of Michigan, Detroit, Michigan, United States
Food Effect Study of AG-221 in Healthy Male Subjects
- First Posted Date
- 2014-08-18
- Last Posted Date
- 2015-12-14
- Lead Sponsor
- Agios Pharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02218346
A Phase I Study of AG-348 in Healthy Volunteers
- First Posted Date
- 2014-05-29
- Last Posted Date
- 2014-11-10
- Lead Sponsor
- Agios Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT02149966
A Phase I Study of AG-348 in Healthy Volunteers
- First Posted Date
- 2014-04-09
- Last Posted Date
- 2014-10-22
- Lead Sponsor
- Agios Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT02108106
© Copyright 2025. All Rights Reserved by MedPath